Home | Our portfolio | Tech ventures | ADC Biotechnology

ADC Biotechnology

  • Investment summary:

    ADC Biotechnology develops new process technology to speed, simplify and significantly lower the costs of the production of the latest generation of anti-cancer drugs.

    Finance Wales led a syndicated co-investment with Acceleris. Initial and follow on investment used to progress towards commercialisation.

  • Total investment:
    undisclosed
  • Total Finance Wales investment:
    £510,000
  • Investment type:
    Equity
  • Purpose:
    Tech ventures
  • Executives:
    Paul Lee